Navigation Links
Is Evidence-based Medicine Enough to Support Additional Research in Alternative Medicine?

Evidence-based medicine (EBM) is acclaimed as the "gold-standard" amongst researchers for scientific studies. On the one hand, EBM has shown //support and on the other, has also questioned the worth of allopathic medicine practices, during the least interaction phase with complementary and alternative medicine (CAM) practices. Majority of CAM practices are difficult, and concentrate on healing rather than cure.

The question arises as to whether EBM principles are sufficient for making clinical decisions about CAM. That is the focus of this special issue of Integrative Cancer Therapies by SAGE Publications.

"While evidence-based medicine's emphasis on randomized controlled trials has many benefits, researchers and clinicians have found that this focus may be too limited for complex systems such as complementary and alternative medicine (CAM), and other approaches to healing," said Wayne B. Jonas, MD, president and chief executive officer of the Samueli Institute and this special issue's guest editor.

The December special issue of Integrative Cancer Therapies presents articles that explore EBM and alternative strategies to EBM for evaluating CAM and in particular, options for conducting CAM research on cancer. This issue discusses whether clinical research on CAM using randomized placebo-controlled trial designs is the best strategy for making evidence-based decisions in clinical practice, and describes strategies that use "whole systems" and "integrated evaluation models" as potential new standards for research on CAM for cancer.

The second half of this special issue then explores whether basic science adds value to a debate recently resurrected in "The Lancet" on the value of research on homeopathy. Integrative Cancer Therapies now reports a series of landmark studies on the effects of homeopathy on prostate cancer. These are the first rigorous studies on homeopathy simultaneously using genetic, cellular and whole anima l models of cancer. These studies show that rigorous basic science research can be conducted on this controversial CAM practice and that current evidence warrants continued research on this approach for cancer.

Source-Eurekalert
'"/>




Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Prince Charles lends support to Alternative Medicine
3. Healthy Medicine Or Harmful Intoxicant?
4. Medicines on the move
5. A surge in Lifestyle Medicine
6. Does Your Prescription Have An Inappropriate Medicine?
7. The Use Of Alternative Medicine On The Rise
8. New Medicine For Parkinson’s disease
9. Advent of New, More Effective and Personalized Medicines
10. Combing Hair More Effective Than OTC Medicine For Head Lice
11. Heart Patients Use Alternative Medicine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
(Date:10/12/2017)... ... , ... Leading pediatric oncology experts at Children’s National Health System ... of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired by ... Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief of the ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Diplomat Pharmacy, Inc. (NYSE: DPLO ... LLC , and named its founder as Diplomat,s chief ... Tennessee , will operate under Diplomat subsidiary ... offerings for health care partners to include IT outsourcing, ... "In an interoperable world, technology delivers comprehensive insight ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/25/2017)... PROVIDENCE, R.I. , Sept. 25, 2017 /PRNewswire/ ... immunogenicity assessment, vaccine design, and immune-engineering today announced ... focused on the development of personalized therapeutic cancer ... and has provided exclusive access to enabling technologies ... MSc Eng., MBA will lead EpiVax Oncology as ...
Breaking Medicine Technology: